Rutherford Health Plc
("Rutherford" or "the Company")
Placing update
11 October 2021
Further to its announcement of 4 October 2021, the Company announces that the date by which funds are to be received under the placing of 19 million new Rutherford ordinary shares of
-Ends-
For more information, please contact:
Rutherford Health plc |
+44 (0) 16 3381 0661 |
Michael Moran, Chief Executive Officer |
Investors@therutherford.com |
|
|
Grant Thornton (Corporate Adviser) |
+44 (0) 20 7383 5100 |
Colin Aaronson / George Grainger |
|
|
|
Instinctif Partners |
+44 207 457 2020 |
Melanie Toyne-Sewell / Jeremy Durrant / Rozi Morris |
Rutherford@Instinctif.com |
|
|
Media House International |
07788 414 856 / 0207 710 0020 |
Ramsay Smith |
ramsay@mediahouse.co.uk |
About Rutherford Health plc
Rutherford Health plc is a leading
The Company is listed on the Apex segment of the AQSE Growth Market under the symbol: RUTH. For more information, visit the Group's website: www.rutherfordhealth.com .
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.